NOT KNOWN FACTUAL STATEMENTS ABOUT KEY PERFORMANCE INDICATORS REVENUE CYCLE

The trial is now delayed. The sponsor is not pleased, meaning CRO X will not be the primary choice for a next trial. This, consequently, brings CRO X back to sq. 1, again to assessing their basic KPI.As you recognize, IRB approval is frequently one of the very first milestones while in the lifetime cycle of the clinical trial. Make use of your supe